Co-Diagnostics (CODX) Stock Price, Quote, News & History | Benzinga

Co-Diagnostics Inc (CODX) Stock Price, Quote, News & History

CODXNASDAQ

Trade with Public

Trade with Public

$1.12

N/A

At close: Sep 8, 5:00 PM EST

$1.14

0.021.79%

Pre-Market: 4:00 AM EST

OverviewNews Earnings Forecast Events Price Targets Financials Sentiment Ownership Compare Stock Report

Key Statistics

Open

-

Close

$1.12

Volume / Avg.

322.00 / 438.30K

Day Range

- - -

52 Wk Range

0.94 - 46.50

Market Cap

$7.96M

P/E Ratio

-

Dividend Yield

-

Exchange

NASDAQ

RSI

31

Short Interest

5.29%

Days to Cover

1.07

Recent Co-Diagnostics Inc News

Stock Market Today: S&P 500, Dow, Nasdaq 100 Futures Fall as Oil Tops $99 Despite Trump’s Price Drop Prediction— ASML, NVS, CASY in Focus (UPDATED)

Stock Market Today: S&P 500, Dow Futures Fall as Oil Tops $99 Despite Trump’s Price Drop Prediction— ASML, NVS, CASY in Focus

Rishabh Mishra

United Natural Foods, ABM Industries and 3 Stocks to Watch Heading Into Tuesday

Stocks in focus: UNFI and ABM earnings, Novartis trial miss, Co-Diagnostics CFO change, and Casey’s earnings expected.

Avi Kapoor

Merck-Backed Lab Gets $8.5 Million to Fast-Track a Vaccine for a Rapidly Spreading Ebola Outbreak

Merck and Wellcome-backed Hilleman will manufacture Bundibugyo Ebola vaccine doses for clinical trials with up to $8.5M in CEPI funding.

Tanya Rawat

EXCLUSIVE: Co-Diagnostics Announces Successful Proof of Concept for Extraction-Free Ebola Test

Co-Diagnostics advances its Ebola testing capabilities, sending Bundibugyo virus test kits for evaluation and completing a new assay study.

Vandana Singh

Why Forte Biosciences Shares Are Trading Higher By 39%; Here Are 20 Stocks Moving Premarket

Forte Biosciences shares rose 38.9% to $76.10 in pre-market trading after argenx SE announced plans to acquire the company for $77 per share.

Avi Kapoor

Financials

Quarterly

Annual

Name

Revenue Change
Gross Change
EBITDA Change
EBIT Change
Earnings Change

Cash Flows

Operating Cash Flow (TTM)

-27.10M

Investing Cash Flow (TTM)

1.54M

Financing Cash Flow (TTM)

18.10M

Free Cash Flow (TTM)

-27.47M

Capital Expenditure (TTM)

-367.37K

Net Change in Cash (TTM)

-7.47M

Analyst Rating and Forecast

4.0

Buy

Strong Buy

Buy

Hold

Sell

Strong Sell

Valuation Metrics

Enterprise Value

$5.97M

PE Ratio (TTM)

-

PE Ratio (FWD)

-

PEG Ratio (TTM)

-

PS Ratio (TTM)

3.77

PB Ratio (TTM)

0.62

Earnings Yield % (TTM)

-2311.61%

Earnings Yield % (FWD)

-74.11%

EV / EBITDA (TTM)

-

Price / EBITDA (TTM)

-

Price / Free Cash Flow (TTM)

-

Book Value / Share

$1.82

Company Debt

Total Debt

-

LT Debt

-

LT Debt Issuance (TTM)

-

LT Debt Repayment (TTM)

-

Total Cash

$3.65M

Debt to Equity

0.14

Issuance of Debt (TTM)

-

Repayment of Debt (TTM)

-

Key Statistics

Open

-

Close

$1.12

Volume / Avg.

322.00 / 438.30K

Day Range

- - -

52 Wk Range

0.94 - 46.50

Market Cap

$7.96M

P/E Ratio

-

Dividend Yield

-

Exchange

NASDAQ

RSI

31

Short Interest

5.29%

Days to Cover

1.07

About

Sector

Health Care

Industry

Health Care Equipment & Supplies

Co-Diagnostics Inc is a molecular diagnostics company. The company develops, manufactures, licenses, and commercializes reagents used for diagnostic tests that function via the detection and/or analysis of nucleic acid molecules (DNA or RNA), includi...

Show More

Edge Rankings

Stock Score Locked: Want to See it?

Benzinga Rankings give you vital metrics on any stock – anytime.

Reveal Full Score

Compare

EPS worse than industry

Earnings Per Share

EPS is the portion of a company's profit allocated to each outstanding share of common stock. It is a key metric for investors to assess a company's profitability.

Earnings Per Share

EPS is the portion of a company's profit allocated to each outstanding share of common stock. It is a key metric for investors to assess a company's profitability.

EPS worse than industry

FAQ

Q

How do I buy Co-Diagnostics (CODX) stock?

A

You can purchase shares of Co-Diagnostics (NASDAQ:CODX) through any online brokerage.

View our list of the best stock brokerages

Q

Who are Co-Diagnostics (CODX) competitors?

A

Other companies in Co-Diagnostics’s space includes: Abbott Laboratories (NYSE:ABT), Intuitive Surgical Inc (NASDAQ:ISRG), Medtronic PLC (NYSE:MDT), Stryker Corp (NYSE:SYK) and Boston Scientific Corp (NYSE:BSX).

Q

What is the forecast, or price target, for Co-Diagnostics (CODX) stock?

A

Co-Diagnostics has a consensus price target of $3.00.

Q

What is the current price for Co-Diagnostics (CODX)?

A

The stock price for Co-Diagnostics (NASDAQ: CODX) is $1.14 last updated September 10, 2026 at 7:09 AM EDT.

Q

Does Co-Diagnostics (CODX) pay a dividend?

A

There are no upcoming dividends for Co-Diagnostics.

Q

When is Co-Diagnostics (NASDAQ:CODX) reporting earnings?

A

Co-Diagnostics does not have any upcoming earnings scheduled.

Q

Is Co-Diagnostics (CODX) going to split?

A

There is no upcoming split for Co-Diagnostics.

Q

What sector and industry does Co-Diagnostics (CODX) operate in?

A

Co-Diagnostics is in the Health Care sector and Health Care Equipment & Supplies industry. They are listed on the NASDAQ.